-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2020 to Q2 2024.
- Inhibikase Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 7.22M shares, a 36.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)